Orphan nuclear receptor NR4A2 induces transcription of the immunomodulatory peptide hormone prolactin

[1]  S. Thébault,et al.  Prolactin promotes cartilage survival and attenuates inflammation in inflammatory arthritis. , 2013, The Journal of clinical investigation.

[2]  A. Griffioen,et al.  Functional consequences of prolactin signalling in endothelial cells: a potential link with angiogenesis in pathophysiology? , 2012, Journal of cellular and molecular medicine.

[3]  S. Abramson,et al.  Orphan nuclear receptor NR4A2 induces synoviocyte proliferation, invasion, and matrix metalloproteinase 13 transcription. , 2012, Arthritis and rheumatism.

[4]  S. Safe,et al.  Structure-dependent activation of NR4A2 (Nurr1) by 1,1-bis(3'-indolyl)-1-(aromatic)methane analogs in pancreatic cancer cells. , 2012, Biochemical pharmacology.

[5]  S. Kuhara,et al.  Gene expression analysis of rheumatoid arthritis synovial lining regions by cDNA microarray combined with laser microdissection: up-regulation of inflammation-associated STAT1, IRF1, CXCL9, CXCL10, and CCL5 , 2012, Scandinavian journal of rheumatology.

[6]  Jing Zhao,et al.  The orphan nuclear receptor Nur77 regulates decidual prolactin expression in human endometrial stromal cells. , 2011, Biochemical and biophysical research communications.

[7]  J. Vencovský,et al.  Elevated prolactin levels in patients with rheumatoid arthritis: association with disease activity and structural damage. , 2010, Clinical and experimental rheumatology.

[8]  E. Morand,et al.  Identification of NURR1 as a mediator of MIF signaling during chronic arthritis: effects on glucocorticoid-induced MKP1. , 2010, The American journal of pathology.

[9]  D. Bruemmer,et al.  NR4A orphan nuclear receptors: transcriptional regulators of gene expression in metabolism and vascular biology. , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[10]  R. Moriggl,et al.  Stat5 Promotes Survival of Mammary Epithelial Cells through Transcriptional Activation of a Distinct Promoter in Akt1 , 2010, Molecular and Cellular Biology.

[11]  R. Perez-Fernandez,et al.  The Pit-1/Pou1f1 transcription factor regulates and correlates with prolactin expression in human breast cell lines and tumors , 2010, Endocrine-related cancer.

[12]  G. Firestein,et al.  Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis , 2010, Immunological reviews.

[13]  D. Kane,et al.  Identification of NR4A2 as a transcriptional activator of IL-8 expression in human inflammatory arthritis. , 2009, Molecular immunology.

[14]  G. Wagner,et al.  HoxA-11 and FOXO1A Cooperate to Regulate Decidual Prolactin Expression: Towards Inferring the Core Transcriptional Regulators of Decidual Genes , 2009, PloS one.

[15]  S. Abramson,et al.  Transcriptional Repression of Matrix Metalloproteinase Gene Expression by the Orphan Nuclear Receptor NURR1 in Cartilage* , 2007, Journal of Biological Chemistry.

[16]  S. Makarov,et al.  An essential role of NF-κB in the “tumor-like” phenotype of arthritic synoviocytes , 2006, Proceedings of the National Academy of Sciences.

[17]  John C. Scatizzi,et al.  A cell-cycle independent role for p21 in regulating synovial fibroblast migration in rheumatoid arthritis , 2006, Arthritis research & therapy.

[18]  L. Pattacini,et al.  Tumor necrosis factor-alpha protects synovial cells from nitric oxide induced apoptosis through phosphoinositide 3-kinase Akt signal transduction. , 2006, The Journal of rheumatology.

[19]  C. Lavalle,et al.  Prolactin inhibits the apoptosis of chondrocytes induced by serum starvation. , 2006, The Journal of endocrinology.

[20]  J. Rivera,et al.  Matrix metalloproteases from chondrocytes generate an antiangiogenic 16 kDa prolactin , 2006, Journal of Cell Science.

[21]  P. Tontonoz,et al.  Regulation of macrophage inflammatory gene expression by the orphan nuclear receptor Nur77. , 2006, Molecular endocrinology.

[22]  A. Parker,et al.  Nurr1 dependent regulation of pro-inflammatory mediators in immortalised synovial fibroblasts , 2005, Journal of Inflammation.

[23]  B. Bresnihan,et al.  Modulation of Orphan Nuclear Receptor NURR1 Expression by Methotrexate in Human Inflammatory Joint Disease Involves Adenosine A2A Receptor-Mediated Responses1 , 2005, The Journal of Immunology.

[24]  M. Hahne,et al.  Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Induces Rheumatoid Arthritis Synovial Fibroblast Proliferation through Mitogen-activated Protein Kinases and Phosphatidylinositol 3-Kinase/Akt* , 2005, Journal of Biological Chemistry.

[25]  E. Hooghe-Peters,et al.  Mechanism of Prostaglandin (PG)E2-Induced Prolactin Expression in Human T Cells: Cooperation of Two PGE2 Receptor Subtypes, E-Prostanoid (EP) 3 and EP4, Via Calcium- and Cyclic Adenosine 5′-Monophosphate-Mediated Signaling Pathways1 , 2004, The Journal of Immunology.

[26]  P. Accornero,et al.  Leptin and prolactin modulate the expression of SOCS-1 in association with interleukin-6 and tumor necrosis factor-α in mammary cells: a role in differentiated secretory epithelium , 2004, Regulatory Peptides.

[27]  P. Petrow,et al.  Cooperation of Ras- and c-Myc-dependent pathways in regulating the growth and invasiveness of synovial fibroblasts in rheumatoid arthritis. , 2004, Arthritis and rheumatism.

[28]  J. Pelletier,et al.  Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts , 2004 .

[29]  P. Ordentlich,et al.  Identification of the Antineoplastic Agent 6-Mercaptopurine as an Activator of the Orphan Nuclear Hormone Receptor Nurr1* , 2003, Journal of Biological Chemistry.

[30]  P. Oettgen,et al.  Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumour necrosis factor α , 2003, Annals of the rheumatic diseases.

[31]  C. Kessler,et al.  An Ets motif in the proximal decidual prolactin promoter is essential for basal gene expression. , 2002, Journal of molecular endocrinology.

[32]  E. Delgado-Baeza,et al.  Prolactin is a component of the human synovial liquid and modulates the growth and chondrogenic differentiation of bone marrow-derived mesenchymal stem cells , 2002, Molecular and Cellular Endocrinology.

[33]  B. Bresnihan,et al.  Activation of Nuclear Orphan Receptor NURR1 Transcription by NF-κB and Cyclic Adenosine 5′-Monophosphate Response Element-Binding Protein in Rheumatoid Arthritis Synovial Tissue1 , 2002, The Journal of Immunology.

[34]  R. Mcmurray,et al.  Bromocriptine in rheumatic and autoimmune diseases. , 2001, Seminars in arthritis and rheumatism.

[35]  B. Bresnihan,et al.  Involvement of the nuclear orphan receptor NURR1 in the regulation of corticotropin-releasing hormone expression and actions in human inflammatory arthritis. , 2001, Arthritis and rheumatism.

[36]  Y. Saeki,et al.  Enhanced expression and DNA binding activity of two CCAAT/enhancer‐binding protein isoforms, C/EBPβ and C/EBPδ, in rheumatoid synovium , 2000 .

[37]  H. Nagafuchi,et al.  Prolactin locally produced by synovium infiltrating T lymphocytes induces excessive synovial cell functions in patients with rheumatoid arthritis. , 1999, The Journal of rheumatology.

[38]  B. Gellersen,et al.  CCAAT/Enhancer-binding Proteins Are Mediators in the Protein Kinase A-dependent Activation of the Decidual Prolactin Promoter* , 1999, The Journal of Biological Chemistry.

[39]  D. Ray,et al.  The human prolactin gene upstream promoter is regulated in lymphoid cells by activators of T-cells and by cAMP. , 1999, Journal of molecular endocrinology.

[40]  J. Martial,et al.  Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Nolla,et al.  High serum prolactin levels in men with rheumatoid arthritis. , 1998, The Journal of rheumatology.

[42]  E. Seftor,et al.  Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene. , 1998, The American journal of pathology.

[43]  J. Kriegsmann,et al.  Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. , 1996, The American journal of pathology.

[44]  J. Martial,et al.  Characterization of an up-stream promoter directing extrapituitary expression of the human prolactin gene. , 1994, Molecular endocrinology.

[45]  B. Gellersen,et al.  Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma. , 1994, Molecular endocrinology.

[46]  L. Yu-Lee.  Prolactin stimulates transcription of growth-related genes in Nb2 T lymphoma cells. , 1990, Molecular and cellular endocrinology.

[47]  B. Gellersen,et al.  Prolactin (PRL) mRNA from human decidua differs from pituitary PRL mRNA but resembles the IM-9-P3 lymphoblast PRL transcript , 1989, Molecular and Cellular Endocrinology.

[48]  H. Eibel,et al.  Characterization of SV40 T antigen immortalized human synovial fibroblasts: maintained expression patterns of EGR-i, HLA-DR and some surface receptors , 2005, Rheumatology International.

[49]  J. Brosens,et al.  Functional association of PR and CCAAT/enhancer-binding protein beta isoforms: promoter-dependent cooperation between PR-B and liver-enriched inhibitory protein, or liver-enriched activatory protein and PR-A in human endometrial stromal cells. , 2002, Molecular endocrinology.

[50]  A. Kaneko,et al.  Involvement of cAMP responsive element binding protein (CREB) in the synovial cell hyperfunction in patients with rheumatoid arthritis. , 2000, Clinical and experimental rheumatology.

[51]  Y. Saeki,et al.  Enhanced expression and DNA binding activity of two CCAAT/enhancer-binding protein isoforms, C/EBPbeta and C/EBPdelta, in rheumatoid synovium. , 2000, Arthritis and rheumatism.